Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest update is out from Alfresa Holdings ( (JP:2784) ).
Alfresa Holdings has completed a ¥14.99 billion share repurchase, buying 6,307,800 common shares, equivalent to 3.5% of its outstanding stock excluding treasury shares, through the Tokyo Stock Exchange’s off-auction ToSTNeT-3 system on May 18, 2026. The buyback is positioned as part of a flexible capital policy aimed at improving capital efficiency and enhancing shareholder returns, and it also finalizes the terms of a previously announced third-party stock acquisition rights issuance linked to a fully committed share repurchase, potentially tightening the share base and signaling confidence in future performance.
The most recent analyst rating on (JP:2784) stock is a Hold with a Yen2400.00 price target. To see the full list of analyst forecasts on Alfresa Holdings stock, see the JP:2784 Stock Forecast page.
More about Alfresa Holdings
Alfresa Holdings Corporation is a leading player in Japan’s healthcare industry, operating across ethical and OTC pharmaceutical wholesaling, pharmaceutical manufacturing, dispensing pharmacies, regenerative medicine, and CRO services. Listed on the Tokyo Stock Exchange under ticker 2784, the group reported consolidated revenue of ¥3.1 trillion for the fiscal year ended March 31, 2026, underscoring its scale in the domestic healthcare supply chain.
YTD Price Performance: -0.84%
Average Trading Volume: 360,514
Technical Sentiment Signal: Buy
Current Market Cap: Yen453.8B
See more insights into 2784 stock on TipRanks’ Stock Analysis page.